Mechanism of action: Pilsicainide ballicule
What it isClass IC sodium channel blocker; atrial fibrillation in Japan.
Why this onePure sodium channel blockade with a pill-in-the-pocket role.
What limits itThe CAST proarrhythmia concern applies. Renally cleared; not US-approved.
Molecular structure: Pilsicainide
FDA-approved for
- cardiac arrhythmias (Japan)
Off-label
- atrial fibrillation (approved in Japan)
Principal riskThe CAST proarrhythmia concern applies
Classes and tags
Clinical profile
Therapeutic safety burden3 / 4
Overdose danger3 / 4
Weight-gain liability0 / 4
Sedation liability1 / 4
QT / Torsades1 / 4
Direct muscarinic antagonism0 / 4
Defining liabilityRenally amplified conduction slowing and life-threatening proarrhythmia
Open Pilsicainide in the interactive console ↗